Brief: Vicore Pharma Resolves On Share Issue Of Around SEK 160 Mln

Vicore Pharma Holding AB

30/11/2018 07:07

Nov 30 (Reuters) - Vicore Pharma Holding AB  VICOR.ST :
    * VICORE PHARMA'S BOARD OF DIRECTORS HAS RESOLVED ON A
DIRECTED
SHARE ISSUE OF AROUND SEK 160 MILLION TO FINANCE THE CONTINUED
DEVELOPMENT OF THE DRUG DEVELOPMENT PROGRAMS VP01 AND VP02
    * SUBSCRIPTION PRICE HAS BEEN DETERMINED THROUGH A SO-CALLED
BOOK
BUILDING PROCEDURE
    * VICORE PHARMA HOLDING - PROCEEDS WILL ENABLE COMPANY'S
CONTINUED
DEVELOPMENT OF DRUG DEVELOPMENT PROGRAMS VP01 AND VP02 UP TO
IMPORTANT EVENTS

Source text for Eikon:  ID:nWkrjGP9q 
Further company coverage:  VICOR.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))